Vijay is one of the key founding members of Clonz.
His 19 years of industrial experience in the field of cell culture and fermentation specifically upstream of mammalian cell lines to produce biotherapeutics is a significant asset of the company.
Vijay’s experience at a pharmaceutical giant during the development of various therapeutic biosimilar monoclonal antibodies is a major strength.
His expertise in cell culture and fermentation also contributed to excel in his previous assignments for the development of biosimilars.
Contact Vijay at: firstname.lastname@example.org
Clonz biotech was founded in 2010 by an experienced team of recognized leaders in biosimilar research and manufacturing.